UPMC Hematology & Oncology Fellowship Program
@PittHemeOnc
Followers
703
Following
217
Media
55
Statuses
135
Pittsburgh, PA
Joined December 2018
Celebrating at the end of a year of hard work and incredible accomplishments @PittHemeOnc @UPMCHillmanCC @xako22 @ronanhsieh @ManishaDrB
0
3
25
Congrats to second year fellows @xako22 and @MasoodPashaSyed on their recent opinion review article "Debates in Treatment Sequencing in ALK-Rearranged NSCLC"🎉🥳👏🩸 #pitthemeonc
https://t.co/U5NNhHxRx1
dailynews.ascopubs.org
The impact of alectinib on the overall survival of patients with ALK-rearranged NSCLC is impressive.
1
0
9
So excited to be in-person at #ASCOQLTY22 in Chicago! Presenting a poster at 7 am 10/1 about @PittHemeOnc QI work, here to soak up the thoughtful work and discuss how to transform cancer care delivery! Will tweet so you can follow along!
2
3
28
What a great experience at #FDA_ASCOFellowsDay. Great to meet faculty and peers. Learned so much about drug approval and regulations. Thank you for this opportunity @ASCO @FDAOncology @PittHemeOnc @UPMCHillmanCC
1
1
32
Congratulations to our third year fellow Joe Franz on his publication "No needles needed: All-oral therapy options for relapsed and refractory multiple myeloma" 🎉🥳👏🩸 #pitthemeonc
https://t.co/QYuOijcHgl
0
2
15
Dear friends at #ESMO22 Do you follow #OncoAlert 🚨? Awesome!! What about your colleagues? Tell a friend about your #OncoAlert Network & lets keep colleagues worldwide up to date‼️ We're all #OncoAlert 🌐 By colleagues...For colleagues! @OncoAlert 🚨 & @weoncologists
0
5
5
Congratulations to our third year fellow @tsagianni and former fellow @KonLontos on their publication "A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML" 🎉🥳👏🩸 #pitthemeonc
https://t.co/LUAFxpBJCT
tandfonline.com
Published in Leukemia & Lymphoma (Vol. 63, No. 13, 2022)
0
3
9
Check out our great first year fellows enjoying some quality time together with their families! 👶👫🌲 #pitthemeonc #WorkLifeBalance
1
1
31
Congratulations to first year fellow, Urvashi Joshi, on her recent publication "Patterns of use and outcomes of peripherally inserted central catheters in hospitalized patients with solid tumors: A multicenter study" 👏🥳🎉 #pitthemeonc
https://t.co/arFYLefckq
acsjournals.onlinelibrary.wiley.com
Peripherally inserted central catheters were associated with significant complications in hospitalized patients with solid malignancies and often were used for reasons other than chemotherapy....
0
0
10
The @OncoAlert 🚨 @ecancer Weekly RoundUp Aug1⃣5⃣-Aug2⃣1⃣/22 Best @weoncologists 🤠 @shilpaonc @DrChoueiri @HKennecke @EileenMOReilly @GIcancerDoc @ArndtVogel @jillfeldman4 @jrgralow
@DrHBurstein @rachnatshroff @CathyEngMD
@PGrivasMDPhD @ScottJDawseyMD @drenriquegrande
2
33
58
Congratulations to second year fellow @AseelSoqi and former fellows @KonLontos on their recent publication "Time from diagnosis to treatment is associated with survival in patients with acute myeloid leukaemia" 👏🥳🎉 #pitthemeonc
https://t.co/dYhBOJqOGi
onlinelibrary.wiley.com
Acute myeloid leukaemia (AML) is conventionally thought of as a medical emergency. However, several studies on the association of time from diagnosis to treatment with survival did not have concord...
0
1
13
Congratulations to our amazing @PittHemeOnc class of 2022! So incredibly proud of all of you @KarapetLilit @MaxJLee @SabaShaikhMD @UPMCHillmanCC
0
6
34
Welcome home from #vailworkshop to three of our fellows--Emily, Ronan, and Aseel--hope you learned a lot and had a nice time catching up with Saba, our recent grad! Looking good guys 👀👓
0
0
17
Congratulations to our own @jasonlukemd on being elected @sitcancer At-Large Director! @UPMCHillmanCC @PittHemeOnc
We are pleased to announce the results of the 2022 SITC Election. These leaders are ready to contribute to the society's bright future beginning in January 2023. A big thank you to this year’s candidates and voters! View results: https://t.co/L1wszJ1tf8
#MakingCureaReality
0
2
5
We are thrilled to have been selected by ASH to help train the next generation of academic hematologists! 🩸🩸👏👏#pitthemeonc
ASH is excited to announce the Hematology-Focused Fellowship Training Program! By awarding a total of $19 million to 9 institutions across the U.S. for the launch of 10 new fellowship tracks, we aim to address the need to expand the hematology workforce: https://t.co/jBGkejgUsJ
0
4
21
Thank you @ConquerCancerFd for supporting our work in advancing care of patients with #Melanoma. A team work by @JHziyu Sam Guild @AIMatMelanoma @UPMCHillmanCC Thank you mentors @mgibson21212 @jasonlukemd Dr Walter J Storkus @jmkirkwood for all the education and opportunities!
We’re proud to support 97 promising physicians with their work to help patients through quality #cancerresearch in clinical #oncology. Meet the 2022 recipients of the Conquer Cancer Young Investigator Awards (YIA)!
1
1
8
The Impact of the COVID-19 Pandemic on Cancer Care and Outcomes https://t.co/1NyJNpAWGX
#ASCODailyNews @ASCO. Great work by incoming @PittHemeOnc fellow Dr. Kainat Saleem. @UPMC @UPMCHillmanCC
dailynews.ascopubs.org
The impact of the ongoing COVID-19 pandemic on health, health care, and health care workers is unmatched in recent history, both in terms of its extent and significance.
1
1
7
Congratulations to three of our fellows on acceptance into the prestigious AACR/ASCO "Vail" Workshop! 👏Ronan Hsieh (2nd year fellow) 👏 Emily Geramita (2nd year fellow) 👏 Aseel Alsouqi (1st year fellow) We are so proud of you! 🥳🎉🥂 #MedEd #pitthemeonc
0
5
26
Congrats to our first year fellow, Rosie, on winning the fellows teaching competition! #pitthemeonc #meded
4
1
34
👋👋Come rotate with us! ➡️You will learn from our amazing faculty @ldc_paz and @EnricoNovelli2 and meet our special patients https://t.co/FnjeSpbQXZ
#advocate4sickle #ash #pitthemeonc
0
0
5